Health ❯ Healthcare ❯ Regulation

Drug Approval

Counterfeit Drugs FDA Leadership Changes Therapeutic Goods Administration Anvisa Safety Standards Clinical Trials E-cigarettes FDA Brazilian Health Authorities MHRA

Oral GLP‑1 Approval and New Trials Push Weight‑Loss Drugs Into Mass Market

Pill approvals and large sales forecasts are accelerating global uptake while tightening coverage and exposing safety and long‑term care gaps.

George Tidmarsh Takes Helm at FDA Biologics Center, Stoking Independence Concerns